What drugs does AVID RADIOPHARMS INC make?

AVID RADIOPHARMS INC has 2 FDA-approved drugs including TAUVID, AMYVID.

What therapeutic areas does AVID RADIOPHARMS INC focus on?

AVID RADIOPHARMS INC focuses primarily on Neurology.

← Back

Data updated: Mar 29, 2026

AVID RADIOPHARMS INC

Neurology

Specialty

AVID RADIOPHARMS INC is a specialty pharmaceutical company focused on Neurology. Key products include TAUVID.

2012

Since

Drugs

Trials

Approved (2yr)

Key Drugs

TAUVID

flortaucipir f-18

CNS

MAO-A 3 indications · 2020

AMYVID

florbetapir f-18

CNS

Amyloid beta plaques 2 indications · 2012

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

AMYVID 2025-06-23

Efficacy

SEC Filings ProEarly access

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 100%

2 drugs

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

Bristol-Myers Squibb big-pharma

Neurology

AVID RADIOPHARMS INC

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (2)

Active (2)

Discontinued (0)

Company Info

AVID RADIOPHARMS INC

Set Alert

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (2)

Active (2)

Discontinued (0)

Company Info